We are live on
!
Find out more
STA
Summit Trail Advisors Portfolio holdings
AUM
$6.98B
1-Year Est. Return
19.51%
This Fund
S&P 500
This Quarter
Est. Return
+8.75%
1 Year Est. Return
+19.51%
3 Year Est. Return
+56.03%
5 Year Est. Return
+59.89%
10 Year Est. Return
–
AUM
$286M
AUM Growth
-$303M
(-51%)
Cap. Flow
-$454M
Cap. Flow
% of AUM
-158.75%
Top 10 Holdings %
Top 10 Hldgs %
56.26%
Holding
737
New
313
Increased
12
Reduced
146
Closed
255
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.48M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$2.59M |
| 3 |
Vanguard Information Technology ETF
VGT
|
+$2.2M |
| 4 |
iPath Select MLP ETN
ATMP
|
+$1.65M |
| 5 |
TWOU
2U Inc
TWOU
|
+$1.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$46.6M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$25.1M |
| 3 |
Shutterstock
SSTK
|
+$20.8M |
| 4 |
Apple
AAPL
|
+$20.2M |
| 5 |
Enterprise Products Partners
EPD
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 31.69% |
| 2 | Technology | 14.68% |
| 3 | Financials | 10.23% |
| 4 | Consumer Discretionary | 6.02% |
| 5 | Healthcare | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Genpact
G
$5.3B
| $231K | 0.08% |
+8,000
| New | +$247K |
|
127
Pediatrix Medical
MD
$2.16B
| $228K | 0.08% |
+5,262
| New | +$252K |
|
128
Qorvo
QRVO
$7.63B
| $224K | 0.08% |
2,796
-2,122
| -43% | -$164K |
|
|
CCMP
129
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $223K | 0.08% |
+2,061
| New | +$226K |
|
130
iShares Core MSCI EAFE ETF
IEFA
$186B
| $221K | 0.08% |
+3,492
| New | +$231K |
|
|
QVCGA
131
DELISTED
QVC Group Inc Series A
QVCGA
| $221K | 0.08% |
214
-9
| -4% | -$9.96K |
|
|
WIFI
132
DELISTED
Boingo Wireless, Inc.
WIFI
| $219K | 0.08% |
9,691
-31,792
| -77% | -$727K |
|
133
3M
MMM
$89B
| $218K | 0.08% |
1,328
-2,154
| -62% | -$368K |
|
134
Armstrong World Industries
AWI
$6.86B
| $217K | 0.08% |
+3,427
| New | +$204K |
|
135
Trade Desk
TTD
$8.13B
| $215K | 0.08% |
22,900
-76,750
| -77% | -$541K |
|
|
NBLX
136
DELISTED
Noble Midstream Partners LP
NBLX
| $211K | 0.07% |
+4,140
| New | +$200K |
|
137
Nutrien
NTR
$32.7B
| $208K | 0.07% |
3,806
-35,470
| -90% | -$1.76M |
|
138
GSK
GSK
$103B
| $206K | 0.07% |
4,038
-8,264
| -67% | -$416K |
|
139
Vanguard Energy ETF
VDE
$10.1B
| $206K | 0.07% |
1,949
| – | – |
|
140
Warner Bros
WBD
$64.6B
| $200K | 0.07% |
7,283
-13,364
| -65% | -$319K |
|
141
Royal Caribbean
RCL
$78.7B
| $198K | 0.07% |
1,903
-1,812
| -49% | -$199K |
|
142
Grand Canyon Education
LOPE
$3.71B
| $197K | 0.07% |
1,767
-4,297
| -71% | -$472K |
|
143
MetLife
MET
$61B
| $197K | 0.07% |
4,526
-7,589
| -63% | -$354K |
|
|
MPT
144
Medical Properties Trust
MPT
$2.89B
| $196K | 0.07% |
+13,697
| New | +$181K |
|
|
EQM
145
DELISTED
EQM Midstream Partners, LP
EQM
| $195K | 0.07% |
3,789
-16,110
| -81% | -$911K |
|
|
SQBG
146
DELISTED
Sequential Brands Group, Inc.
SQBG
| $191K | 0.07% |
2,427
| – | – |
|
|
TFCF
147
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $186K | 0.07% |
3,781
-75,400
| -95% | -$2.95M |
|
|
AERI
148
DELISTED
Aerie Pharmaceuticals
AERI
| $184K | 0.06% |
2,725
-9,197
| -77% | -$515K |
|
149
Zimmer Biomet
ZBH
$17.7B
| $180K | 0.06% |
+1,660
| New | +$181K |
|
150
Charter Communications
CHTR
$15.2B
| $173K | 0.06% |
589
-939
| -61% | -$270K |
|
Similar funds
SBH
DE
OCA
RBI
PFA
CWM
RPI
EDRH
Summit Trail Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Summit Trail Advisors held 737 positions worth $286M, down 51% from $589M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Summit Trail Advisors withdrew a net $454M in Q2 2018, closing 255 positions and reducing 146 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $46.6M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 32% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Summit Trail Advisors opened a new position in Jazz Pharmaceuticals worth $2.73M.
- Summit Trail Advisors's largest Q2 2018 buy was Jazz Pharmaceuticals: 15,854 shares worth $2.73M.
- Summit Trail Advisors added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $8.48M increase.
- Summit Trail Advisors's biggest Q2 2018 reduction was UnitedHealth, cutting an estimated $7.96M.
- Summit Trail Advisors fully exited Vanguard S&P 500 ETF in Q2 2018, selling an estimated $46.6M.
- Summit Trail Advisors's ten largest holdings make up 56% of its $286M portfolio in Q2 2018.
- Summit Trail Advisors opened 313 new positions and closed 255 in Q2 2018.
- Summit Trail Advisors's portfolio value fell 51% quarter-over-quarter to $286M.
Based on Summit Trail Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.